SIBAmed Studienzentrum GmbH & Co.KG
Leipzig, Germany
Studying center in Leipzig, Saxony
Rosa-Luxemburg-Straße 20, 04103 Leipzig
About SIBAmed Studienzentrum GmbH & Co.KG
"Als hochmodernes Zentrum widmen wir uns ausschließlich der Durchführung von Medikamenten- zulassungsstudien nach internationalen Standards. Unabhängig von Ihrem Versicherungsstatus bieten wir Ihnen einen unmittelbaren Zugang zu den aktuellen und innovativsten Therapiemöglichkeiten. Bei uns können Sie vom medizinischen Fortschritt profitieren und erhalten für Ihr spezifisches Erkrankungsprofil nach umfassender ärztlicher Analyse die neueste Therapiekonzeption. Termine während der Öffnungszeiten und nach Vereinbarung."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Pfizer
2
Bavarian Nordic
1
GWT-TUD GmbH
1
Janssen Research & Development, LLC
1
Janssen Vaccines & Prevention B.V.
1
ModernaTX, Inc.
1
Philip Morris Products S.A.
1
Clinical Trials at SIBAmed Studienzentrum GmbH & Co.KG
During the past decade, SIBAmed Studienzentrum GmbH & Co.KG conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
2018-09-18
2020-05-04
Completed
22
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
2020-06-15
2024-09-30
Active, not recruiting
1,000
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection
2021-09-29
2022-08-12
Completed
1,124
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
2021-10-26
2026-04-06
Recruiting
7,300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SIBAmed Studienzentrum GmbH & Co.KG" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Bavarian Nordic" with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SIBAmed Studienzentrum GmbH & Co.KG"
#1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at SIBAmed Studienzentrum GmbH & Co.KG
According to Clinical.Site data, the most researched conditions in "SIBAmed Studienzentrum GmbH & Co.KG" are
"Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Clostridium Difficile Infection" (1 trials), "Cytomegalovirus Infection" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "SIBAmed Studienzentrum GmbH & Co.KG" in a lesser frequency.
Clinical Trials Intervention Types at SIBAmed Studienzentrum GmbH & Co.KG
Most popular intervention types in "SIBAmed Studienzentrum GmbH & Co.KG" are "Biological" (6 trials), "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ad26.RSV.preF-based Vaccine" (1 trials), "Cigarette smoking" (1 trials), "Clostridium difficile vaccine" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SIBAmed Studienzentrum GmbH & Co.KG
The vast majority of trials in "SIBAmed Studienzentrum GmbH & Co.KG" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at SIBAmed Studienzentrum GmbH & Co.KG
Currently, there are NaN active trials in "SIBAmed Studienzentrum GmbH & Co.KG".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in SIBAmed Studienzentrum GmbH & Co.KG,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SIBAmed Studienzentrum GmbH & Co.KG, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".